Regenxbio Inc. · NASDAQ:RGNX
Pakola Steve sold 56,333 Regenxbio Inc. shares (Form 4)
Traded Jun 29 to Jul 1, 2026 · Filed Jul 1, 2026
From Jun 29 to Jul 1, 2026, Pakola Steve (Chief Medical Officer) sold 56,333 Regenxbio Inc. shares at an average US$12.23 for US$689K, leaving 213,009 shares. Filed Jul 1, 2026 (Form 4).
- Sold
- 56,333 shares
- Price
- US$12.23 average (US$11.04 to US$12.86)
- Value
- US$689K
- Holding after
- 213,009 shares
- Trading plan
- No
- Role
- Chief Medical Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 29, 2026 | Common Stock | Sale | 19,608 | US$11.04 | 213,009 | Direct |
| Jul 1, 2026 | Common Stock | Option exercise | 36,725 | US$7.86 | 249,734 | Direct |
| Jul 1, 2026 | Common Stock | Sale | 36,725 | US$12.86 | 213,009 | Direct |
Source
Related
- Regenxbio Inc.
- Pakola Steve
- Regenxbio Inc. shareholders
- Form 4 · Pakola Steve · Aug 4, 2026
- Form 4 · Pakola Steve · Jul 6, 2026
- Form 4 · Pakola Steve · May 13, 2026
- Schedule 13G · JPMorgan Chase & Co · Oct 13, 2026
- Form 4 · Malzahn Craig · Sep 3, 2026
- Form 4 · Chan Mitchell · Sep 3, 2026
- Form 4 · Ciongoli Gregory Austin · Aug 27, 2026
- Form 4 · Christmas Patrick J. · Aug 4, 2026